Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Rottapharm Madaus GmbH

Home Clinical Trial Sponsors and OrganizationsRottapharm Madaus GmbH

Rottapharm Madaus GmbH

ACTIVE

GermanySubsidiary

Also known as:

rottapharm | madaus gmbh - madaus gmbh -

rottapharm madaus, madaus gmbh

Part of Mylan NV

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

3

2 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Share

Not Applicable

1

33.3%

Trial Status Distribution

Active, not recruiting

2

66.7%

Suspended

1

33.3%

Clinical Trials

Trials sponsored by this organization (3)

Effect of a nutritional supplement with vitamins, magnesium and Rhodiola rosea extract on psychophysiological stress reactions in women during periods of stress

Oct 2014150 participants

Multicenter, randomized, double-blind, placebo-controlled parallel group study to demonstrate the efficacy (quality of life) and safety of the standardized mistletoe extract PS76A2 during chemotherapy and follow-up in patients with breast cancer

Active, not recruiting

Sep 2009320 participants

Multicenter, randomized, double-blind, placebo-controlled parallel group study to demonstrate the efficacy (quality of life) and safety of the standardized mistletoe extract PS76A2 during chemotherapy and follow-up in patients with breast cancer

Active, not recruiting

Aug 2009320 participants

Approvals

No approval data available

News

No news articles found

On this page

Overview
Clinical Trials3
Approvals
News

Back to Organizations